Kela E - Search Results

1

Risk factors of invasive Haemophilus influenzae type b disease among children in Finland.

Takala AK, Eskola J, Palmgren J, Rönnberg PR, Kela E, Rekola P, Mäkelä PH. Takala AK, et al. Among authors: kela e. J Pediatr. 1989 Nov;115(5 Pt 1):694-701. doi: 10.1016/s0022-3476(89)80644-4. J Pediatr. 1989. PMID: 2809900

2

Epidemiology of invasive pneumococcal infections in children in Finland.

Eskola J, Takala AK, Kela E, Pekkanen E, Kalliokoski R, Leinonen M. Eskola J, et al. Among authors: kela e. JAMA. 1992 Dec 16;268(23):3323-7. JAMA. 1992. PMID: 1453524

3

Antibody responses to four Haemophilus influenzae type b conjugate vaccines.

Käyhty H, Eskola J, Peltola H, Rönnberg PR, Kela E, Karanko V, Saarinen L. Käyhty H, et al. Among authors: kela e. Am J Dis Child. 1991 Feb;145(2):223-7. doi: 10.1001/archpedi.1991.02160020117030. Am J Dis Child. 1991. PMID: 1994693

4

Susceptibility to invasive Haemophilus influenzae type b disease and the immunoglobulin G2m(n) allotype.

Takala AK, Sarvas H, Kela E, Rönnberg PR, Mäkelä PH. Takala AK, et al. Among authors: kela e. J Infect Dis. 1991 Mar;163(3):637-9. doi: 10.1093/infdis/163.3.637. J Infect Dis. 1991. PMID: 1995735

5

Reactogenicity and immunogenicity of combined vaccines for bacteraemic diseases caused by Haemophilus influenzae type b, meningococci and pneumococci in 24-month-old children.

Eskola J, Käyhty H, Takala A, Rönnberg PR, Kela E, Peltola H. Eskola J, et al. Among authors: kela e. Vaccine. 1990 Apr;8(2):107-10. doi: 10.1016/0264-410x(90)90131-5. Vaccine. 1990. PMID: 2110703 Clinical Trial.

6

A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease.

Eskola J, Käyhty H, Takala AK, Peltola H, Rönnberg PR, Kela E, Pekkanen E, McVerry PH, Mäkelä PH. Eskola J, et al. Among authors: kela e. N Engl J Med. 1990 Nov 15;323(20):1381-7. doi: 10.1056/NEJM199011153232004. N Engl J Med. 1990. PMID: 2233904 Free article. Clinical Trial.

7

Immunogenicity of Haemophilus influenzae oligosaccharide-protein and polysaccharide-protein conjugate vaccination of children at 4, 6, and 14 months of age.

Käyhty H, Peltola H, Eskola J, Rönnberg PR, Kela E, Karanko V, Mäkelä PH. Käyhty H, et al. Among authors: kela e. Pediatrics. 1989 Dec;84(6):995-9. Pediatrics. 1989. PMID: 2587155

8

Increased risk of primary invasive Haemophilus influenzae type B disease in twins.

Takala AK, Rönnberg PR, Kela E, Eskola J, Mäkelä M. Takala AK, et al. Among authors: kela e. Pediatr Infect Dis J. 1989 Nov;8(11):799-800. doi: 10.1097/00006454-198911000-00014. Pediatr Infect Dis J. 1989. PMID: 2594455 No abstract available.

9

Risk factors for primary invasive pneumococcal disease among children in Finland.

Takala AK, Jero J, Kela E, Rönnberg PR, Koskenniemi E, Eskola J. Takala AK, et al. Among authors: kela e. JAMA. 1995 Mar 15;273(11):859-64. JAMA. 1995. PMID: 7869556

10

Preceding respiratory infection predisposing for primary and secondary invasive Haemophilus influenzae type b disease.

Takala AK, Meurman O, Kleemola M, Kela E, Rönnberg PR, Eskola J, Mäkelä PH. Takala AK, et al. Among authors: kela e. Pediatr Infect Dis J. 1993 Mar;12(3):189-95. doi: 10.1097/00006454-199303000-00003. Pediatr Infect Dis J. 1993. PMID: 8451094

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters